Benefits Of Home-based Multidisciplinary Rehabilitation In Non Small Cell Lung Cancer
Funder
National Health and Medical Research Council
Funding Amount
$581,039.00
Summary
Lung cancer is the third leading cause of death in Australia. People with lung cancer experience a complex mix of symptoms that can provoke significant distress and impair physical function. This study aims to develop and test a home based exercise and self-management support program to increase function and physical activity levels, reduce levels of depression and improve quality of life of people with lung cancer.
An MRI Study Of Emotional Processing Deficits In Childhood
Funder
National Health and Medical Research Council
Funding Amount
$578,985.00
Summary
The ability to recognise and process emotions in other people is fundamental to healthy social interactions. Conduct disordered children with callous and unemotional traits have difficulty recognizing fearful expressions, possibly due to lack of attention to cues such as facial expressions that healthy people naturally attend to. This study will use neuroimaging to determine if brain activity changes to look more like typically developing children if their gaze is redirected to facial cues of em ....The ability to recognise and process emotions in other people is fundamental to healthy social interactions. Conduct disordered children with callous and unemotional traits have difficulty recognizing fearful expressions, possibly due to lack of attention to cues such as facial expressions that healthy people naturally attend to. This study will use neuroimaging to determine if brain activity changes to look more like typically developing children if their gaze is redirected to facial cues of emotion.Read moreRead less
Targeting Drug-Resistance In Paediatric Acute Lymphoblastic Leukaemia
Funder
National Health and Medical Research Council
Funding Amount
$649,048.00
Summary
Leukaemia is the most common type of cancer in children but resistance to therapy continues to be a significant problem. This project will investigate the biology of drug-resistance and relapse using a mouse model that replicates the human disease. We hope to identify novel therapeutic targets that can be used in combination with existing therapies to improve outcomes in this disease, particularly for patients that develop drug-resistance such as those at the time of relapse.
An International Clinical Trial To Evaluate New Therapies To Improve Survival Of Children With Relapsed Acute Lymphoblastic Leukaemia
Funder
National Health and Medical Research Council
Funding Amount
$1,567,500.00
Summary
Children who relapse with childhood leukaemia have only a 50% chance of being alive after 5 years. We will participate in a new international trial involving most European and all Australian and New Zealand childhood oncology centres, to test the effectiveness of promising new treatments and to perform biological studies which should enable doctors in future to pick the best treatment for each of these patients.